ÌÇÐÄÆƽâ°æ

Oncology

Statistics report about the state of cancer treatment and the oncology market

This report presents key facts and figures about the global and U.S. cancer treatment situation and the oncology market. This report provides a closer look on the market, on companies, top products, research and development, treatment types, etc.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Cancer facts

5
  • Premium Statistic Leading causes of death worldwide in 2019
  • Basic Statistic Cancer deaths worldwide by major type 2022
  • Basic Statistic U.S. Americans with a history of cancer living from 2004 to 2025
  • Premium Statistic Number of new cancer cases in U.S. from 1999 to 2022
  • Premium Statistic Deaths by cancer in the U.S. 1950-2023

Oncology market

6
  • Premium Statistic Global oncology spending 2013-2029
  • Basic Statistic Spending and growth worldwide in oncology market 2025-2029
  • Premium Statistic Oncology medicine spending growth 2014-2018, by region
  • Basic Statistic Predicted oncology spending in 2023, by region
  • Basic Statistic Emerging cancer diagnostics market size by world region 2015 and 2023
  • Basic Statistic Oncology therapeutic market growth U.S. 2016-2021, by segment

Companies

6
  • Premium Statistic Global top 5 companies by forecasted oncology sales 2030
  • Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2025
  • Basic Statistic Celgene's top product revenues 2013-2018
  • Premium Statistic Bristol-Myers Squibb's major products based on revenue, 2023-2025
  • Basic Statistic U.S. venture investments in oncology companies 2006-2023
  • Basic Statistic U.S. oncology company IPO money raised 2006-2023

Cancer drugs

3
  • Premium Statistic Availability of new cancer drugs by country as of 2018
  • Basic Statistic Top U.S. oncology products by revenue in 2016
  • Premium Statistic Number of cancer drugs by cost and number of patients U.S. 2017

Research and development

5
  • Premium Statistic FDA breakthrough drug designations by therapy area 2025
  • Premium Statistic Distribution of late phase oncology pipeline 2008 vs. 2018 by type
  • Premium Statistic Number of cancer drugs in development in the U.S. 2005-2018
  • Premium Statistic Time from R&D start to approval of select cancer drugs 2017
  • Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017

Immuno-oncology

5
  • Basic Statistic Worldwide top drug-producing mechanisms of action by number of active compounds 2026
  • Premium Statistic Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
  • Basic Statistic Global cancer immunotherapy market size 2023-2035
  • Premium Statistic Global cancer immunotherapy sales share by type 2021 forecast
  • Premium Statistic Leading cancer immunotherapy collaborations worldwide by value 2018

Treatment types

5
  • Premium Statistic Distribution of treatment types for female breast cancer by stage in 2021
  • Basic Statistic Distribution of treatment types for prostate cancer 2010-2012
  • Premium Statistic Distribution of treatment types for colon cancer by stage in 2021
  • Premium Statistic Distribution of treatment types for lung cancer in the U.S. in 2021, by stage
  • Basic Statistic Distribution of treatment types for non-Hodgkin lymphoma 2013

Physicians and patients

9
  • Premium Statistic Number of oncologists per one million people by select country 2018
  • Basic Statistic Number of specialty physicians in the U.S. 2026, by field of specialty
  • Basic Statistic Number of oncology specialty physicians in the U.S. 2016
  • Premium Statistic Number of hours U.S. oncologists spend a week seeing patients 2018
  • Premium Statistic Number of minutes U.S. oncologists spend with each patient 2018
  • Basic Statistic Cancer patients using medication in select countries 2018
  • Premium Statistic Cancer sufferers based on lifestyle habits by select country 2019
  • Premium Statistic Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
  • Basic Statistic Patients whose tumors are driven by genetic mutations by cancer type 2016
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch